Skip to content

Xencor XNCR Price / book

Price / book at other companies

Amgen logo
AmgenAMGN
20.6×-6.3×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
2.6×+0.2×
Janux Therapeutics logo
Janux TherapeuticsJANX
0.9×-0.7×
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
1.1×+0.5×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
125.1×+108×
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
4.1×+0.5×

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Calculated from Xencor’s reported figures.

Based on the most recent quarter.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's price / book?
Xencor (XNCR) reported price / book of 1.7× in Q1 2026.
How has Xencor's price / book changed year-over-year?
Xencor's price / book increased by 46.4% year-over-year, from 1.2× to 1.7×.
What is the long-term trend for Xencor's price / book?
Over 5 years (2020 to 2025), Xencor's price / book has grown at a -17.3% compound annual growth rate (CAGR), from 4.5× to 1.7×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.